Tolebrutinib introduces a promising shift in the management of non-relapsing secondary progressive multiple sclerosis, a disease of the brain and spinal cord (1). By addressing smoldering neuroinflammation, it opens the door to earlier and more proactive intervention in disability progression.
1020 Reached
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Male with Urethral Bleeding due to Insertion of Telephone Wire in Urethra
2466 Reached4 Comments6 Likes
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
Complicated case of Osteoarthritis
1850 Reached2 Comments3 Likes